The rollercoaster ride in markets in 2018 continues this year, and these are some driving factors to watch out for.
Puerto Rico's financial crisis is getting worse, and it is wise for investors to avoid putting their money on the island.
Eli Lilly & Co. makes second major pharmaceutical deal this year by paying cancer drug specialists Loxo Oncology $8 billion.
Big companies have set their eyes about going public this year. With analysts predicting a looming recession and the ongoing global trade tension, however, is it...
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
What are dividend aristrocrats and how should you consider them when investing?
Macy’s has been at the forefront of asset sales activity during the last few years, and here, we take a look at what the department store...
Investing in stocks during your retirement would depend on how much risk you can take. Here are some things to consider.
What should people know about angel investing? One investor shares his own experience as an angel investor.
Firsthand Technology Value Fund’s Kevin Landis avoids some FAANG stocks, embraces others and fills his portfolio with smaller, innovative companies.